Patent: 10,653,754
✉ Email this page to a colleague
Summary for Patent: 10,653,754
Title: | Highly pure neurotoxic component of a botulinum toxin and uses thereof |
Abstract: | The present invention relates to a process for preparing a highly pure neurotoxic component of a toxin by cultivating under conditions that allow production of a toxin, and isolating the neurotoxic component from the toxin. In addition, the present invention relates to a highly pure neurotoxic component of a toxin obtainable by the process of the present invention and uses thereof. |
Inventor(s): | Pfeil Michael, Wiesenburg Andreas |
Assignee: | Merz Pharmaceuticals GmbH |
Application Number: | US15881135 |
Patent Claims: | see list of patent claims |
Details for Patent 10,653,754
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merz Pharmaceuticals Gmbh C/o Merz Pharmaceuticals Llc | XEOMIN | incobotulinumtoxina | For Injection | 125360 | July 30, 2010 | ⤷ Subscribe | 2038-01-26 |
Merz Pharmaceuticals Gmbh C/o Merz Pharmaceuticals Llc | XEOMIN | incobotulinumtoxina | For Injection | 125360 | November 20, 2015 | ⤷ Subscribe | 2038-01-26 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |